EN DE
Watch Shiseido Company Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Shiseido Company Limited (SSDOF) fair value: what the stock is really worth

As of Oct 26, 2026: fair value (intrinsic value) of Shiseido Company Limited stock $14.54, price $23.00, that is 36.8% below the price, quality 53 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive US · Based in Japan

SC Shiseido Company Limited logo Some data Nov 17, 2026

Shiseido Company Limited

SSDOF · US

Far too expensive (fair value 37% below the price) and falling price, but solid company: meets 1 of 3 rules.

Get notified free when this changes
Low debt 
Generates free cash flow 
1.7% dividend yield · Cash covered
Quality 53/100 
Recent news mixed 
Some data 
Fair value $14.54 · Strongly overvalued 
Falling price (downtrend) 
Weak Growth (revenue 5y +1.1 %/yr in JPY) 
Loss-making · -2.1% net margin (TTM) 
Trails peers (2/14) 
Narrow moat 23/100 · thin data
⚠ Thinly traded

Main risks:

🚩China market dependence🚩Korean and Chinese rivals
Watch Shiseido Company Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$67.47 $3.17 Fair Value $14.54 Jul 2015 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.

How to read this chart

60‑month range $3.17 – $67.47 · fair‑value band $10.05 – $19.17 · the $23.00 price screens above the $14.54 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 17, 2026.

Follow Shiseido Company in your weekly email

Every Wednesday you see whether Shiseido Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Shiseido Company, Limited produces and sells in Japan and internationally. It offers fragrances, skincare, and makeup products through retail channels. The company also engages in the restaurant and food businesses; and operates beauty salons.

Show moreShow less

In addition, it operates and supports SABFA, a professional hair makeup training school. Further, the company manages childcare facilities.

It serves its products under the BAUM, BENEFIQUE, Clé de Peau Beauté, Dr. Dennis Gross Skincare, Drunk Elephant, EFFECTIM, Gallinée, INOUI, IPSA, ISSEY MIYAKE PARFUMS, NARS, narciso rodriguez, Serge Lutens, SHISEIDO, THE GINZA, Tory Burch Beauty, ZADIG&VOLTAIRE, ANESSA, AQUA LABEL, AUPRES, d program, ELIXIR, HAKU, INTEGRATE, MAJOLICA MAJORCA, MAQuillAGE, PRIOR, REVITAL, URARA, INRYU, The Collagen, and Perfect Cover brands.

The company sells its products through department, specialized cosmetic, drug, and general merchandise stores. Shiseido Company, Limited was founded in 1872 and is headquartered in Chuo, Japan.

Stock analysis

Shiseido Company Limited (SSDOF) currently trades at $23.00, while our model-based Fair Value estimate is $14.54, 37% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $14.54 per share, and 0 of the 12 models we run sit above the $23.00 price.

Bear case: the Asset-Based group reads lowest at $3.86, and 12 of the 12 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $10.05 (bear) to $19.17 (bull), the price of $23.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Consumer Defensive sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Shiseido Company Limited reported revenue of ¥971B in FY2025 versus ¥1.0T in FY2021, a compound −1.6%/yr. Reported net income was −¥40.7B in FY2025.

Key figures

Market cap $9.2B Mid · EPS (TTM) $−0.3300 · Dividend yield 1.7% · Net margin −4.2% · Return on equity −3.1% · Return on assets (EBIT) 2.1% (5-year average) · Operating margin 11.1% · Revenue (TTM) ¥999B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and 56% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −33% fair-value upside, at −37%, SSDOF screens richer than that median.

Fair Value models

Bear $10.05 Fair Value $14.54 Bull $19.17
Price $23.00 · Downside -36.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $10.01 $14.54 $22.23 80
Growth DCF $10.45 $14.84 $21.83 78
5Y EBITDA Exit $10.29 $16.04 $23.02 75
All 14 models by family
DCF Models
FCF DCF $10.01 $14.54 $22.23 80
Owner Earnings n/a n/a $0.4200 73
5Y Revenue Exit $4.22 $5.57 $7.32 74
5Y EBITDA Exit $10.29 $16.04 $23.02 75
10Y Revenue Exit $6.21 $7.75 $9.39 68
10Y EBITDA Exit $10.08 $14.81 $20.29 69
Earnings-Based
EPV n/a $0.1700 $0.3700 68
Multiples
EV/EBIT n/a $1.03 $2.20 61
EV/EBITDA $10.05 $14.61 $19.17 67
EV/Revenue n/a n/a $1.00 50
Asset-Based
NCAV (Graham) $2.88 $3.86 $5.76 54
Growth DCF
Growth DCF $10.45 $14.84 $21.83 78
Rev-Margin DCF $4.22 $5.79 $7.72 73
Economic Profit
ROIC Compounder n/a $0.1700 $0.3700 68

Open the full fair value analysis →

Quality Score breakdown

Overall quality 53/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 32
How much profit the company makes from its sales and capital
Quality Growth 43
Are margins and returns getting better?
Cashflow 42
Do the profits arrive as real cash?
Financial strength 41
Debt, balance sheet and risk of trouble
Investment 95
Does it invest with discipline instead of growing at any price?
Low Volatility 49
How calm the share price moves, does not count
Price momentum 38
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 64
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 25/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−2.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.1%
Start year 2020 (pandemic). Over 10 years: +2.4% a year
Revenue growth 30 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
1.6% (2020) → 1.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+10.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.3%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about +8.0% a year for the price and +1.1% for the forecasts.
Forecast 2026 (sales)+4.7%
Forecast 2027 (sales)+3.1%
Projected 2028 (sales)+3.0%
Projected 2029 (sales)+2.8%
Projected 2030 (sales)+2.7%

SSDOF screens overvalued: fair value 37% below the price. Compare with Colgate-Palmolive Company →

Recent news

News mood ⓘNews mood, the average tone of recent news (46 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.
Note from the team Nov 7, 2026
AI conclusion: The business draws strength from its VOYAGER AI platform that speeds up cosmetic formulation and R&D efficiency, yet faces its main weakness in sustained net losses and cash flow pressure from established brands.
Main risk: Regulatory tightening on resellers and geopolitical tensions in China could sharply reduce sales and margins in its key travel retail and domestic China channels.
Bull case: By accelerating diversification beyond China and investing in AI-enhanced R&D for differentiated prestige skincare, Shiseido could rebuild balanced regional sales and protect margins.
Bear case: Persistent weakness in China combined with share losses to Asian rivals could force deeper brand exits, prolonged cost cuts and a structurally smaller, less profitable business.
Shiseido applies its VOYAGER AI platform to sift through tens of thousands of possible cosmetic formulations and narrow them to a handful for human review, as demonstrated with the Dual Blooming Mist UV. This approach could sharpen R&D efficiency in a crowded personal care market, yet the business still faces pressure on cash flow generation from its established brands. Will the gains in formulation speed and new product hits outweigh the drag from slower core segments?
Join the discussion →

Compare Shiseido Company Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 241 stocks

Beats the industry median on 2/13 measures
Overall it trails its industry peers.
Valuation
Quality Score 53 · Below median
Fair Value upside −36.8% · Bottom 25%
Profitability
Return on assets −3.2% · Bottom 25%
Net margin (12 months) −2.1% · Bottom 25%
Operating margin (12 months) 11.1% · Above median
Growth and dividend
Revenue growth (quarter YoY) 10.5% · Above median
Dividend yield (12 months) 1.7% · Below median
Balance sheet
Debt / equity 0.30× · Above median

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/B 2.43× · Pricier than median
P/S (12 months) 1.46× · Pricier than median
Price / free cash flow (fiscal year) 22.3× · Pricier than median
EV/EBITDA 15.5× · Pricier than median
PEG 2.12× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 33
FUTURE (revenue growth)53 · sector 21
PAST (return on equity)0 · sector 29
HEALTH (low debt)85 · sector 98
DIVIDEND (yield)33 · sector 53

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Godrej Consumer Products Limited GODREJCP ₹892.70 ₹1,146 +28% vs SSDOF
Puig Brands, S.A PUIG €20.44 €24.28 +19% vs SSDOF
Henkel AG HEN €79.50 €83.75 +5% vs SSDOF
Beiersdorf Aktiengesellschaft, BEI €83.46 €69.09 −17% vs SSDOF
The Clorox Company CLX $110.17 $74.29 −33% vs SSDOF
Church & Dwight Co CHD $114.74 $65.04 −43% vs SSDOF
Colgate-Palmolive Company CL $100.99 $56.16 −44% vs SSDOF
Marico Limited MARICO ₹913.65 ₹493.84 −46% vs SSDOF
The Estée Lauder Companies Inc EL $108.61 $44.21 −59% vs SSDOF
Hindustan Unilever Limited HINDUNILVR ₹2,000 ₹775.25 −61% vs SSDOF

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Shiseido Company Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Shiseido Company Limited Fair Value". https://www.fairvalue-calculator.com/stock/SSDOF

Frequently asked questions

Is Shiseido Company Limited (SSDOF) overvalued or undervalued?
As of Nov 17, 2026, our model estimates a fair value of $14.54 versus the last price from Oct 26, 2026 of $23.00, about 37% lower (overvalued).
What is the fair value of SSDOF?
Our model-based fair value for Shiseido Company Limited is $14.54 (as of Nov 17, 2026), built from audited fundamentals. Last price (from Oct 26, 2026): $23.00.
What is the quality score of SSDOF?
Shiseido Company Limited has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Shiseido Company Limited (SSDOF)?
Our model-based price target is the fair value of $14.54 (as of Nov 17, 2026) from 14 valuation models. Cautious scenario $10.05, optimistic scenario $19.17. It is a calculation from audited fundamentals, not an analyst target.
What is the Shiseido Company Limited stock forecast for 2026?
Our models put fair value at $14.54, about 37% lower versus the last price from Oct 26, 2026 of $23.00 (overvalued). Cautious scenario $10.05, optimistic scenario $19.17. The calculation is refreshed regularly with new filings.
What is the revenue of Shiseido Company Limited (SSDOF)?
Shiseido Company Limited reported trailing-twelve-month revenue of about ¥999B (latest available figure, as of Nov 17, 2026).
Does Shiseido Company Limited pay a dividend?
Shiseido Company Limited currently shows a dividend yield of 1.65% relative to its recent price (as of Nov 17, 2026).
How much is the dividend of Shiseido Company Limited (SSDOF) and when is the ex-dividend date?
Shiseido Company Limited has a dividend yield of 1.7%. The next ex-dividend date is Dec 29, 2026. A dividend has been paid every year since at least 2002. Free cash flow covers the dividend 5.45 times. Our assessment: Cash covered. The dividend is fully funded by free cash flow. The payout ratio on earnings is not available for this company.
What growth is priced into Shiseido Company Limited (SSDOF)?
For today's price to be fair in a discounted-cash-flow model, Shiseido Company Limited would have to grow free cash flow by 10.3 % per year for five years (discount rate 8.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 1.1 % per year. As of Nov 17, 2026.
What discount rate (WACC) does the fair value of SSDOF use?
Our models discount Shiseido Company Limited at 8.7 %: a base by market capitalisation (mid), damped by beta 0.58, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Shiseido Company Limited that is +10.3 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.7 %) and the same formula as our fair value.
How much growth has Shiseido Company Limited (SSDOF) delivered so far?
Over the past 5 years revenue at Shiseido Company Limited grew 1.1 % a year. The price currently implies free-cash-flow growth of +10.3 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Shiseido Company Limited (SSDOF) growing?
The median revenue growth in the sector is +4.0 % a year. That is the yardstick for the growth priced into Shiseido Company Limited (+10.3 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Shiseido Company Limited (SSDOF)?
The free-cash-flow yield on the price is 4.47 %: that much free cash flow Shiseido Company Limited produces per unit of market value. When it exceeds the discount rate of our models (8.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Shiseido Company Limited (SSDOF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Shiseido Company Limited it is $14.54 per share (as of Nov 17, 2026), against a price of $23.00. It is the blended result of 14 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Shiseido Company Limited stock overvalued or undervalued in 2026?
As of Nov 17, 2026, SSDOF trades above its calculated fair value: price $23.00, fair value $14.54, a gap of about −37% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SSDOF?
No. The price is what the market pays today ($23.00); the fair value is what the company's own numbers justify ($14.54). For Shiseido Company Limited the two are $8.46 per share apart. That gap is exactly why we show both numbers side by side.
How much is Shiseido Company Limited worth?
The market values Shiseido Company Limited at about $9.2B (market capitalisation, as of Nov 17, 2026). Per share that is $23.00; our models calculate a fair value of $14.54 per share.
What do the bullish and bearish scenarios say about SSDOF?
Our models span a range for Shiseido Company Limited: cautious scenario $10.05, base $14.54, optimistic $19.17 per share (as of Nov 17, 2026, price $23.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of SSDOF?
The PEG ratio of Shiseido Company Limited is 2.12 (P/E divided by earnings growth, as of Nov 17, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Shiseido Company Limited (SSDOF)?
Balance-sheet figures for Shiseido Company Limited (as of Nov 17, 2026): return on equity −3.1%, debt of 0.30 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is SSDOF from its 52-week high?
Shiseido Company Limited trades at $23.00, at its 52-week high of $23.00 and 56% above the low of $14.75 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of $14.54 is for.
Which stocks are comparable to Shiseido Company Limited?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, The Estée Lauder Companies Inc, Henkel AG, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Shiseido Company Limited stock attractive at the current price?
The data as of Nov 17, 2026: price $23.00, calculated fair value $14.54 (−37%), Quality Score 53/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SSDOF calculated?
We run Shiseido Company Limited through 14 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of $14.54 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Shiseido Company Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Shiseido Company Limited (SSDOF)?
The latest price we hold is from Oct 26, 2026 and stands at $23.00. Our model-based fair value is $14.54, about 37% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Shiseido Company Limited right now?
The price sits above even our optimistic bull case ($19.17). The favourable scenario is already priced in. Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($10.05 to $19.17) leaves room in how you read the outcome.

Key figures of Shiseido Company Limited

How large is the market capitalisation of Shiseido Company Limited (SSDOF)?
The market capitalisation of Shiseido Company Limited is $9.2B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Shiseido Company Limited (SSDOF)?
Earnings per share at Shiseido Company Limited are $−0.3300. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Shiseido Company Limited (SSDOF)?
The dividend yield of Shiseido Company Limited is 1.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Shiseido Company Limited (SSDOF)?
The net margin of Shiseido Company Limited is −4.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Shiseido Company Limited (SSDOF)?
The return on equity (ROE) of Shiseido Company Limited is −3.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Shiseido Company Limited (SSDOF)?
On an EBIT basis the return on assets of Shiseido Company Limited is 2.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Shiseido Company Limited (SSDOF)?
The operating margin of Shiseido Company Limited is 11.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Shiseido Company Limited (SSDOF)?
Revenue at Shiseido Company Limited is growing 10.5% versus a year earlier (3y avg −3.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Shiseido Company Limited (SSDOF)?
Earnings per share at Shiseido Company Limited are growing 265% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Shiseido Company Limited (SSDOF) carry?
The net debt of Shiseido Company Limited is ¥231B (fiscal year 2025, ≈ 3.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Shiseido Company Limited in the live analysis

One click puts Shiseido Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.